GenVault and Diligent Pharma discuss effective CAPA use, business continuity drills, and real-world root cause analysis to enhance quality in clinical trials.
We’re excited to share that GenVault has partnered with Diligent Pharma, a company renowned for its expertise in quality and risk management in the clinical trial industry. This collaboration is a great step forward for GenVault, as it highlights our dedication to maintaining the highest standards in life sciences. After
Maintaining the integrity and security of valuable biosamples is paramount in the fast-paced world of scientific research. Unfortunately, costly mistakes can occur.
Billions of biosamples are collected each year for a plethora of studies, including research and clinical applications. One of the most pressing concerns for these samples is storage.
Billions of biosamples are collected each year for a plethora of studies, including research and clinical applications. One of the most pressing concerns for these samples is storage.
Billions of biosamples are collected each year for a plethora of studies, including research and clinical applications. One of the most pressing concerns for these samples is storage.
Not all biorepositories are created equal. Here’s what to seek out in yours. Careful vetting of a prospective biostorage partner is critical. After all, failure to consistently meet biosamples’ exact storage, handling, and transport conditions can cost your bioinventory (and larger research efforts) dearly. Which begs the million-dollar question: How
Biosamples are only as good as their vial labels. Preventing label errors is just one way GenVault protects your invaluable biodata. Biorepository labeling errors happen – and more often than many realize. By some estimates, patient specimen identification errors cause more than 160,000 adverse patient events in the United States
The only commercial biorepository of its kind, GenVault goes above and beyond to provide flexible storage space, advanced securities, and comprehensive support to the research community. The rise of biologic therapeutics research and drug discovery worldwide comes with challenges, including lack of sufficient biorepository space for secure sample storage. By
